Shoulder Innovations (NYSE:SI - Get Free Report)'s stock had its "buy" rating restated by investment analysts at BTIG Research in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $23.00 target price on the stock. BTIG Research's price objective would indicate a potential upside of 51.52% from the company's previous close.
Several other equities research analysts also recently issued reports on the stock. Zacks Research raised shares of Shoulder Innovations to a "hold" rating in a research report on Tuesday, August 26th. Morgan Stanley initiated coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set an "overweight" rating and a $18.00 price objective for the company. Jefferies Financial Group initiated coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set a "buy" rating and a $19.00 price objective for the company. Wall Street Zen downgraded shares of Shoulder Innovations from a "hold" rating to a "sell" rating in a research report on Saturday, August 30th. Finally, Piper Sandler assumed coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They set an "overweight" rating and a $18.00 price objective for the company. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Shoulder Innovations has a consensus rating of "Moderate Buy" and a consensus price target of $19.60.
Get Our Latest Analysis on Shoulder Innovations
Shoulder Innovations Stock Performance
NYSE:SI traded down $0.72 during trading hours on Tuesday, hitting $15.18. The stock had a trading volume of 109,850 shares, compared to its average volume of 169,878. Shoulder Innovations has a one year low of $11.75 and a one year high of $17.94. The company has a market capitalization of $231.19 million and a PE ratio of -0.51.
Insider Transactions at Shoulder Innovations
In other news, major shareholder Lsv Associates Ii, Llc purchased 266,666 shares of the business's stock in a transaction on Friday, August 1st. The stock was purchased at an average price of $15.00 per share, for a total transaction of $3,999,990.00. Following the completion of the purchase, the insider directly owned 1,885,136 shares in the company, valued at $28,277,040. The trade was a 16.48% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael A. Carusi purchased 266,666 shares of the business's stock in a transaction on Friday, August 1st. The stock was purchased at an average price of $15.00 per share, with a total value of $3,999,990.00. Following the purchase, the director owned 1,885,136 shares of the company's stock, valued at approximately $28,277,040. The trade was a 16.48% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 778,382 shares of company stock valued at $11,675,730.
About Shoulder Innovations
(
Get Free Report)
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shoulder Innovations, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shoulder Innovations wasn't on the list.
While Shoulder Innovations currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.